{"id":"https://openalex.org/W3173178613","doi":"https://doi.org/10.1186/s13321-021-00525-z","title":"Nonadditivity in public and inhouse data: implications for drug design","display_name":"Nonadditivity in public and inhouse data: implications for drug design","publication_year":2021,"publication_date":"2021-07-02","ids":{"openalex":"https://openalex.org/W3173178613","doi":"https://doi.org/10.1186/s13321-021-00525-z","mag":"3173178613","pmid":"https://pubmed.ncbi.nlm.nih.gov/34215341"},"language":"en","primary_location":{"id":"doi:10.1186/s13321-021-00525-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13321-021-00525-z","pdf_url":"https://jcheminf.biomedcentral.com/track/pdf/10.1186/s13321-021-00525-z","source":{"id":"https://openalex.org/S180838163","display_name":"Journal of Cheminformatics","issn_l":"1758-2946","issn":["1758-2946"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cheminformatics","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jcheminf.biomedcentral.com/track/pdf/10.1186/s13321-021-00525-z","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084663159","display_name":"Dea Gogishvili","orcid":"https://orcid.org/0000-0001-8809-0861"},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL","SE"],"is_corresponding":false,"raw_author_name":"D. Gogishvili","raw_affiliation_strings":["Department of Computer Science, Vrije Universiteit, De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands","Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Computer Science, Vrije Universiteit, De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]},{"raw_affiliation_string":"Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077542460","display_name":"Eva Nittinger","orcid":"https://orcid.org/0000-0001-7231-7996"},"institutions":[{"id":"https://openalex.org/I4210113007","display_name":"AstraZeneca (Netherlands)","ror":"https://ror.org/021tmn508","country_code":"NL","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210113007"]},{"id":"https://openalex.org/I4210137263","display_name":"AstraZeneca (Finland)","ror":"https://ror.org/035n56j11","country_code":"FI","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210137263"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["FI","NL","SE"],"is_corresponding":true,"raw_author_name":"E. Nittinger","raw_affiliation_strings":["Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. eva.nittinger@astrazeneca.com","Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":"https://orcid.org/0000-0001-7231-7996","affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. eva.nittinger@astrazeneca.com","institution_ids":["https://openalex.org/I4210113007","https://openalex.org/I4210137263"]},{"raw_affiliation_string":"Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016955588","display_name":"Christian Margreitter","orcid":"https://orcid.org/0000-0002-5473-6318"},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"C. Margreitter","raw_affiliation_strings":["Computational Chemistry, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational Chemistry, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051401603","display_name":"Christian Tyrchan","orcid":"https://orcid.org/0000-0002-6470-984X"},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"C. Tyrchan","raw_affiliation_strings":["Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5077542460"],"corresponding_institution_ids":["https://openalex.org/I4210113007","https://openalex.org/I4210137263","https://openalex.org/I4210143795"],"apc_list":{"value":2190,"currency":"USD","value_usd":2190},"apc_paid":{"value":2190,"currency":"USD","value_usd":2190},"fwci":2.5001,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.90338696,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"13","issue":"1","first_page":"47","last_page":"47"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11948","display_name":"Machine Learning in Materials Science","score":0.9781000018119812,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.597392737865448},{"id":"https://openalex.org/keywords/additive-function","display_name":"Additive function","score":0.5479450821876526},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"Drug discovery","score":0.528983473777771},{"id":"https://openalex.org/keywords/substituent","display_name":"Substituent","score":0.44964703917503357},{"id":"https://openalex.org/keywords/ligand","display_name":"Ligand (biochemistry)","score":0.43768760561943054},{"id":"https://openalex.org/keywords/rational-design","display_name":"Rational design","score":0.4292513132095337},{"id":"https://openalex.org/keywords/chemistry","display_name":"Chemistry","score":0.4101862907409668},{"id":"https://openalex.org/keywords/data-mining","display_name":"Data mining","score":0.3861393332481384},{"id":"https://openalex.org/keywords/stereochemistry","display_name":"Stereochemistry","score":0.22838714718818665},{"id":"https://openalex.org/keywords/mathematics","display_name":"Mathematics","score":0.18748432397842407},{"id":"https://openalex.org/keywords/nanotechnology","display_name":"Nanotechnology","score":0.13651111721992493}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.597392737865448},{"id":"https://openalex.org/C38803922","wikidata":"https://www.wikidata.org/wiki/Q95745348","display_name":"Additive function","level":2,"score":0.5479450821876526},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.528983473777771},{"id":"https://openalex.org/C2778689049","wikidata":"https://www.wikidata.org/wiki/Q898422","display_name":"Substituent","level":2,"score":0.44964703917503357},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.43768760561943054},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.4292513132095337},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4101862907409668},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.3861393332481384},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.22838714718818665},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.18748432397842407},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.13651111721992493},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.1186/s13321-021-00525-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13321-021-00525-z","pdf_url":"https://jcheminf.biomedcentral.com/track/pdf/10.1186/s13321-021-00525-z","source":{"id":"https://openalex.org/S180838163","display_name":"Journal of Cheminformatics","issn_l":"1758-2946","issn":["1758-2946"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cheminformatics","raw_type":"journal-article"},{"id":"pmid:34215341","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34215341","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cheminformatics","raw_type":null},{"id":"pmh:oai:research.vu.nl:openaire_cris_publications/d5304b31-49c1-483c-8be1-0d230ac51e9c","is_oa":true,"landing_page_url":"https://research.vu.nl/en/publications/d5304b31-49c1-483c-8be1-0d230ac51e9c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gogishvili, D, Nittinger, E, Margreitter, C & Tyrchan, C 2021, 'Nonadditivity in public and inhouse data: implications for drug design', Journal of Cheminformatics, vol. 13, 47, pp. 1-18. https://doi.org/10.1186/s13321-021-00525-z","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8254291","is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8254291","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J Cheminform","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:17641e4b847843349772997d01307d1d","is_oa":true,"landing_page_url":"https://doaj.org/article/17641e4b847843349772997d01307d1d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Cheminformatics, Vol 13, Iss 1, Pp 1-18 (2021)","raw_type":"article"},{"id":"pmh:oai:research.vu.nl:openaire/d5304b31-49c1-483c-8be1-0d230ac51e9c","is_oa":true,"landing_page_url":"https://hdl.handle.net/1871.1/d5304b31-49c1-483c-8be1-0d230ac51e9c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Gogishvili, D, Nittinger, E, Margreitter, C & Tyrchan, C 2021, 'Nonadditivity in public and inhouse data: implications for drug design', Journal of Cheminformatics, vol. 13, 47, pp. 1-18. https://doi.org/10.1186/s13321-021-00525-z","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:research.vu.nl:publications/d5304b31-49c1-483c-8be1-0d230ac51e9c","is_oa":true,"landing_page_url":"http://www.scopus.com/inward/record.url?scp=85109145890&partnerID=8YFLogxK","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Gogishvili, D, Nittinger, E, Margreitter, C & Tyrchan, C 2021, 'Nonadditivity in public and inhouse data: implications for drug design', Journal of Cheminformatics, vol. 13, 47, pp. 1-18. https://doi.org/10.1186/s13321-021-00525-z","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1186/s13321-021-00525-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13321-021-00525-z","pdf_url":"https://jcheminf.biomedcentral.com/track/pdf/10.1186/s13321-021-00525-z","source":{"id":"https://openalex.org/S180838163","display_name":"Journal of Cheminformatics","issn_l":"1758-2946","issn":["1758-2946"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cheminformatics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6399999856948853,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324119","display_name":"Uppsala Universitet","ror":"https://ror.org/048a87296"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3173178613.pdf","grobid_xml":"https://content.openalex.org/works/W3173178613.grobid-xml"},"referenced_works_count":70,"referenced_works":["https://openalex.org/W1968748040","https://openalex.org/W1969943857","https://openalex.org/W1972978214","https://openalex.org/W1974971448","https://openalex.org/W1977637450","https://openalex.org/W1993122091","https://openalex.org/W2005073192","https://openalex.org/W2005518172","https://openalex.org/W2007647898","https://openalex.org/W2010013752","https://openalex.org/W2015782150","https://openalex.org/W2025557696","https://openalex.org/W2028734972","https://openalex.org/W2031609935","https://openalex.org/W2034585379","https://openalex.org/W2041282815","https://openalex.org/W2045192688","https://openalex.org/W2055903184","https://openalex.org/W2061624733","https://openalex.org/W2066412916","https://openalex.org/W2078047235","https://openalex.org/W2088970363","https://openalex.org/W2097472327","https://openalex.org/W2101234009","https://openalex.org/W2102384571","https://openalex.org/W2102562821","https://openalex.org/W2106579606","https://openalex.org/W2116594819","https://openalex.org/W2120484655","https://openalex.org/W2123768455","https://openalex.org/W2128691366","https://openalex.org/W2145602919","https://openalex.org/W2148512505","https://openalex.org/W2154670681","https://openalex.org/W2314067773","https://openalex.org/W2319432648","https://openalex.org/W2322193123","https://openalex.org/W2329862012","https://openalex.org/W2332135472","https://openalex.org/W2332655091","https://openalex.org/W2526925775","https://openalex.org/W2558999090","https://openalex.org/W2578240541","https://openalex.org/W2580919858","https://openalex.org/W2583907533","https://openalex.org/W2608559058","https://openalex.org/W2610148085","https://openalex.org/W2761181345","https://openalex.org/W2769423117","https://openalex.org/W2781821160","https://openalex.org/W2784213390","https://openalex.org/W2803615944","https://openalex.org/W2888752364","https://openalex.org/W2895884529","https://openalex.org/W2925830236","https://openalex.org/W2949676527","https://openalex.org/W2951273027","https://openalex.org/W2952635193","https://openalex.org/W2992432290","https://openalex.org/W2999309192","https://openalex.org/W3000593833","https://openalex.org/W3012585755","https://openalex.org/W3014689923","https://openalex.org/W3085022174","https://openalex.org/W3100704554","https://openalex.org/W3104705366","https://openalex.org/W3193532674","https://openalex.org/W4210372362","https://openalex.org/W4241690031","https://openalex.org/W6602045790"],"related_works":["https://openalex.org/W2369066770","https://openalex.org/W2143619931","https://openalex.org/W2311228442","https://openalex.org/W1984949433","https://openalex.org/W1974573029","https://openalex.org/W2150888266","https://openalex.org/W2402574816","https://openalex.org/W2120365564","https://openalex.org/W2045757710","https://openalex.org/W2009118579"],"abstract_inverted_index":{"Numerous":[0],"ligand-based":[1],"drug":[2,76,205],"discovery":[3],"projects":[4],"are":[5,33],"based":[6],"on":[7,190],"structure-activity":[8],"relationship":[9],"(SAR)":[10],"analysis,":[11],"such":[12],"as":[13],"Free-Wilson":[14],"(FW)":[15],"or":[16,55,147],"matched":[17],"molecular":[18],"pair":[19],"(MMP)":[20],"analysis.":[21],"Intrinsically":[22],"they":[23],"assume":[24],"linearity":[25],"and":[26,68,96,115,134,167,200],"additivity":[27,141],"of":[28,44,127,130,171,197],"substituent":[29],"contributions.":[30],"These":[31],"techniques":[32],"challenged":[34],"by":[35],"nonadditivity":[36],"(NA)":[37],"in":[38,48,52,107,117,121,154,179,182,194],"protein-ligand":[39],"binding":[40],"where":[41],"the":[42,61,113,131,169],"change":[43],"two":[45],"functional":[46],"groups":[47],"one":[49],"molecule":[50],"results":[51],"much":[53],"higher":[54],"lower":[56],"activity":[57],"than":[58],"expected":[59],"from":[60,136],"respective":[62],"single":[63],"changes.":[64],"Identifying":[65],"nonlinear":[66],"cases":[67],"possible":[69],"underlying":[70],"explanations":[71],"is":[72,163],"crucial":[73],"for":[74],"a":[75,191],"design":[77],"project":[78],"since":[79],"it":[80],"might":[81],"influence":[82],"which":[83],"lead":[84],"to":[85,165],"follow.":[86],"By":[87],"systematically":[88],"analyzing":[89],"all":[90,128],"AstraZeneca":[91],"(AZ)":[92],"inhouse":[93,114],"compound":[94],"data":[95,123,153,162,173],"publicly":[97],"available":[98],"ChEMBL25":[99],"bioactivity":[100],"data,":[101],"we":[102],"show":[103],"significant":[104,140],"NA":[105,152,185],"events":[106],"almost":[108],"every":[109,118],"second":[110],"assay":[111,120],"among":[112],"once":[116],"third":[119],"public":[122,137],"sets.":[124],"Furthermore,":[125],"9.4%":[126],"compounds":[129],"AZ":[132],"database":[133],"5.1%":[135],"sources":[138],"display":[139],"shifts":[142],"indicating":[143],"important":[144],"SAR":[145],"features":[146],"fundamental":[148],"measurement":[149],"errors.":[150],"Using":[151],"combination":[155],"with":[156],"machine":[157],"learning":[158],"showed":[159],"that":[160],"nonadditive":[161,172],"challenging":[164],"predict":[166],"even":[168],"addition":[170],"into":[174],"training":[175],"did":[176],"not":[177],"result":[178],"an":[180],"increase":[181],"predictivity.":[183],"Overall,":[184],"analysis":[186],"should":[187],"be":[188],"applied":[189],"regular":[192],"basis":[193],"many":[195],"areas":[196],"computational":[198],"chemistry":[199],"can":[201],"further":[202],"improve":[203],"rational":[204],"design.":[206]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":8}],"updated_date":"2026-08-11T07:18:39.950985","created_date":"2025-10-10T00:00:00"}